Skip to content

Regenxbio RGNX Total costs & expenses

Total costs & expenses at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$636.57M+22.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$46.93M+15.7%
Opko Health logo
Opko HealthOPK
$175.21M-19.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$6.4M-92.8%
Gross profit$14.9M+35.7%
Operating income-$83.4M-787%
Net income-$90.1M-1,580%
EPS (diluted)-$1.72-1,533%

Balance sheet

See full
Cash & equivalents$15.2M-88.3%
Total debt$71.1M-11.0%
Total equity$21.1M-92.3%
Total assets$341.9M-30.4%

Cash flow

See full
Operating cash flow-$76.2M-327%
CapEx$1.2M+20.6%
Free cash flow-$77.4M-337%

Valuation

See full
Market cap$529.38M+24.6%
Enterprise value$585.22M+56.3%
P/S+3.3×

Profitability

See full
Gross margin59.7%+1.0pp
Operating margin-292.3%-613pp
Net margin-330.2%-588pp
FCF margin-269.2%-364pp

Returns & leverage

See full
Return on equity-196.4%-288pp
Debt / equity3.4×+3.1×
Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Regenxbio's total costs & expenses?
Regenxbio (RGNX) reported total costs & expenses of $89.76M in Q1 2026.
How has Regenxbio's total costs & expenses changed year-over-year?
Regenxbio's total costs & expenses increased by 16.7% year-over-year, from $76.89M to $89.76M.
What is the long-term trend for Regenxbio's total costs & expenses?
Over 4 years (2021 to 2025), Regenxbio's total costs & expenses has grown at a 1.7% compound annual growth rate (CAGR), from $310.37M to $331.64M.
What does total costs & expenses mean?
This is the aggregate sum of all operating costs, including research and development, selling, general, and administrative expenses, and other operational outlays. It provides a comprehensive view of the company's total burn rate and operational footprint. Investors use this to assess the company's overall cost structure and efficiency in managing its business activities.